Methods Inf Med 2016; 55(05): 431-439
DOI: 10.3414/ME16-01-0035
Original Articles
Schattauer GmbH

A Factor Analysis Approach for Clustering Patient Reported Outcomes[*]

Jung Hun Oh
1   Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
,
Maria Thor
1   Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
,
Caroline Olsson
2   Division of Clinical Cancer Epidemiology, Department of Oncology, University of Gothenburg, Gothenburg, Sweden
,
Viktor Skokic
2   Division of Clinical Cancer Epidemiology, Department of Oncology, University of Gothenburg, Gothenburg, Sweden
,
Rebecka Jörnsten
3   Department of Mathematical Sciences, University of Gothenburg, Gothenburg, Sweden
,
David Alsadius
2   Division of Clinical Cancer Epidemiology, Department of Oncology, University of Gothenburg, Gothenburg, Sweden
,
Niclas Pettersson
2   Division of Clinical Cancer Epidemiology, Department of Oncology, University of Gothenburg, Gothenburg, Sweden
,
Gunnar Steineck
2   Division of Clinical Cancer Epidemiology, Department of Oncology, University of Gothenburg, Gothenburg, Sweden
,
Joseph O. Deasy
1   Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
› Author Affiliations
FundingsThis work was funded by an internal grant from Memorial Sloan Kettering Cancer Center and in part through the NIH / NCI Cancer Center Support Grant P30 CA008748; the Swedish Cancer Society, the King Gustav V Jubilee Clinic Cancer Foundation in Göteborg; the Swedish state under the ALF agreement in Göte-borg; Varian Corporation; and the Assar Gabrielsson Foundation, Tore Nilssons Foundation, and “Syskonen Svenssons fond för medicinsk forskning”.
Further Information

Publication History

Received 14 March 2016

Accepted in revised form: 19 May 2016

Publication Date:
08 January 2018 (online)

Summary

Background: In the field of radiation oncology, the use of extensive patient reported outcomes is increasingly common to meas -ure adverse side effects after radiotherapy in cancer patients. Factor analysis has the potential to identify an optimal number of latent factors (i.e., symptom groups). However, the ultimate goal of treatment response modeling is to understand the relationship between treatment variables such as radiation dose and symptom groups resulting from FA. Hence, it is crucial to identify clinically more relevant symptom groups and improved response variables from those symptom groups for a quantitative analysis. Objectives: The goal of this study is to design a computational method for finding clinically relevant symptom groups from PROs and to test associations between symptom groups and radiation dose. Methods: We propose a novel approach where exploratory factor analysis is followed by confirmatory factor analysis to determine the relevant number of symptom groups. We also propose to use a combination of symptoms in a symptom group identified as a new response variable in linear regression analysis to investigate the relationship between the symptom group and dose-volume variables. Results: We analyzed patient-reported gastrointestinal symptom profiles from 3 datasets in prostate cancer patients treated with radiotherapy. The final structural model of each dataset was validated using the other two datasets and compared to four other existing FA methods. Our systematic EFA-CFA approach provided clinically more relevant solutions than other methods, resulting in new clinically relevant outcome variables that enabled a quantitative analysis. As a result, statistically significant correlations were found between some dose- volume variables to relevant anatomic structures and symptom groups identified by FA. Conclusions: Our proposed method can aid in the process of understanding PROs and provide a basis for improving our understanding of radiation-induced side effects.

1 Supplementary material published on our web-site http://dx.doi.org/10.3414/ME16-01-0035


 
  • References

  • 1 Farnell DJ, Mandall P, Anandadas C, Routledge J, Burns MP, Logue JP. et al. Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy. Radiother Oncol 2010; 97 (Suppl. 01) 136-42.
  • 2 Brandt CA, Cohen DB, Shifman MA, Miller PL, Nadkarni PM, Frawley SJ. Approaches and informatics tools to assist in the integration of similar clinical research questionnaires. Methods Inf Med 2004; 43 (Suppl. 02) 156-62.
  • 3 Hatakeyama Y, Miyano I, Kataoka H, Nakajima N, Watabe T, Yasuda N. et al. Use of a Latent Topic Model for Characteristic Extraction from Health Checkup Questionnaire Data. Methods Inf Med 2015; 54 (Suppl. 06) 515-21.
  • 4 Mulaik S. Foundations of Factor Analysis, Second Edition. Boca Raton (FL): Chapman and Hall/ CRC; 2009
  • 5 Kuku S, Fragkos C, McCormack M, Forbes A. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers. Br J Cancer 2013; 109 (Suppl. 06) 1504-12.
  • 6 Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF. et al. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol 2013; 49 (Suppl. 04) 360-6.
  • 7 Kim HJ, Barsevick AM, Tulman L, McDermott PA. Treatment-related symptom clusters in breast cancer: a secondary analysis. J Pain Symptom Manage 2008; 36 (Suppl. 05) 468-79.
  • 8 Khan L, Cramarossa G, Lemke M, Nguyen J, Zhang L, Chen E. et al. Symptom clusters using the Spitzer quality of life index in patients with brain metastases – a reanalysis comparing different statistical methods. Support Care Cancer 2013; 21 (Suppl. 02) 467-73.
  • 9 Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, Paul SM. et al. Changes in symptom clusters in patients undergoing radiation therapy. Support Care Cancer 2009; 17 (Suppl. 11) 1383-91.
  • 10 Hird A, Wong J, Zhang L, Tsao M, Barnes E, Danjoux C. et al. Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index. Support Care Cancer 2010; 18 (Suppl. 03) 335-42.
  • 11 Steineck G, Bergmark K, Henningsohn L, alAbany M, Dickman PW, Helgason A. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 2002; 41 (Suppl. 03) 244-52.
  • 12 Steineck G, Hunt H, Adolfsson J. A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol 2006; 45 (Suppl. 04) 421-9.
  • 13 Chen B, Chen M, Paisley J, Zaas A, Woods C, Ginsburg GS. et al. Bayesian inference of the number of factors in gene-expression analysis: application to human virus challenge studies. BMC Bioinform 2010; 11: 552.
  • 14 Preacher KJ, Zhang G, Kim C, Mels G. Choosing the Optimal Number ofFactors in Exploratory Factor Analysis: A Model Selection Perspective. Multivariate Behav Res 2013; 48: 28-56.
  • 15 Ruscio J, Roche B. Determining the number of factors to retain in an exploratory factor analysis using comparison data of known factorial structure. Psychol Assess 2012; 24 (Suppl. 02) 282-92.
  • 16 Skerman HM, Yates PM, Battistutta D. Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 2009; 32 (Suppl. 03) 345-60.
  • 17 Alsadius D, Olsson C, Pettersson N, Tucker SL, Wilderäng U, Steineck G. Patient-reported gastrointestinal symptoms among long-term survivors after radiation therapy for prostate cancer. Radiother Oncol 2014; 112 (Suppl. 02) 237-43.
  • 18 Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 245-76.
  • 19 Kaiser HF. The application of electronic computers to factor analysis. Educational and Psychological Measurement 1960; 20: 141-51.
  • 20 Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965; 30: 179-85.
  • 21 Raiche G, Riopel M, Blais J-G. Nongraphical solutions for the Cattell’s scree test. The annual meeting of the Psychometric Society Montreal, Quebec, Canada: 2006
  • 22 Revelle W. psych: Procedures for Personality and Psychological Research. Northwestern University Evanston, Illinois, USA: 2014
  • 23 Rosseel Y. lavaan: An R Package for Structural Equation Modeling. Journal of Statistical Software 2012; 48: 21-36.
  • 24 Poppert Cordts K, Steele RG. An Evaluation of the Children’s Report of Sleep Patterns Using Confirmatory and Exploratory Factor Analytic Approaches. J Pediatr Psychol. 2016
  • 25 Waldenström AC, Alsadius D, Pettersson N, Johansson KA, Holmberg E, Steineck G. et al. Variation in position and volume of organs at risk in the small pelvis. Acta Oncol 2010; 49 (Suppl. 04) 491-9.
  • 26 Fabrigar LR, Wegener DT, MacCallum RC, ve Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods 1999; 4: 272-99.
  • 27 Vordermark D, Schwab M, Ness-Dourdoumas R, Sailer M, Flentje M, Koelbl O. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 2003; 69 (Suppl. 02) 209-14.